{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:02Z","timestamp":1786118942099,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/cji.0b013e318183af26","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T03:10:27Z","timestamp":1221793827000},"page":"723-730","source":"Crossref","is-referenced-by-count":7,"title":["A Polyvalent Cellular Vaccine Induces T-cell Responses Against Specific Self-antigens Overexpressed in Chronic Lymphocytic B-cell Leukemia"],"prefix":"10.1097","volume":"31","author":[{"given":"Konrad","family":"Kronenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfriede","family":"N\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Frankenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Mocikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210219","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1357-4310(97)01049-6","article-title":"Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?","volume":"3","author":"Coulie","year":"1997","journal-title":"Mol Med Today"},{"key":"R2-5-20210219","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nm1295-1297","article-title":"Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity","volume":"1","author":"Mayordomo","year":"1995","journal-title":"Nat Med"},{"key":"R3-5-20210219","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med"},{"key":"R4-5-20210219","first-page":"189","article-title":"Therapiekonzepte Onkologie","author":"Freud","year":"1996"},{"key":"R5-5-20210219","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-0734.2000.00001.x","article-title":"Biology of chronic lymphocytic leukemia","volume":"4","author":"Caligaris-Cappio","year":"2000","journal-title":"Rev Clin Exp Hematol"},{"key":"R6-5-20210219","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood"},{"key":"R7-5-20210219","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3","article-title":"Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression","volume":"69","author":"Aguilar-Santelises","year":"1996","journal-title":"Int J Cancer"},{"key":"R8-5-20210219","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V98.3.814","article-title":"p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation","volume":"98","author":"Pettitt","year":"2001","journal-title":"Blood"},{"key":"R9-5-20210219","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin","volume":"84","author":"Watanabe","year":"1994","journal-title":"Blood"},{"key":"R10-5-20210219","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood.V99.12.4554","article-title":"Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes","volume":"99","author":"Korz","year":"2002","journal-title":"Blood"},{"key":"R11-5-20210219","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.gt.3300875","article-title":"Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype","volume":"6","author":"Selmayr","year":"1999","journal-title":"Gene Ther"},{"key":"R12-5-20210219","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood.V99.4.1327","article-title":"Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells","volume":"99","author":"Kronenberger","year":"2002","journal-title":"Blood"},{"key":"R13-5-20210219","first-page":"2346","article-title":"Trioma-based vaccination against B cell lymphoma confers long-lasting tumor immunity","volume":"57","author":"Mocikat","year":"1997","journal-title":"Cancer Res"},{"key":"R14-5-20210219","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<113::AID-IJC20>3.0.CO;2-J","article-title":"Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells","volume":"83","author":"Strehl","year":"1999","journal-title":"Int J Cancer"},{"key":"R15-5-20210219","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2006.01.019","article-title":"Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia","volume":"245","author":"Allgeier","year":"2007","journal-title":"Cancer Lett"},{"key":"R16-5-20210219","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1479-5876-5-16","article-title":"Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine","volume":"5","author":"Adam","year":"2007","journal-title":"J Translat Med"},{"key":"R17-5-20210219","first-page":"4240","article-title":"Vaccination against B-cell chronic-lymphocytic leukemia with trioma cells: preclinical evaluation","volume":"9","author":"Wahl","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R18-5-20210219","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1479-5876-5-18","article-title":"Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70","volume":"5","author":"Zobywalski","year":"2007","journal-title":"J Transl Med"},{"key":"R19-5-20210219","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"},{"key":"R20-5-20210219","first-page":"2347","article-title":"Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and \u03b3\u03b4 T cells","volume":"62","author":"Schnurr","year":"2002","journal-title":"Cancer Res"},{"key":"R21-5-20210219","first-page":"1515","article-title":"Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice","volume":"60","author":"Egeter","year":"2000","journal-title":"Cancer Res"},{"key":"R22-5-20210219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.exphem.2006.10.006","article-title":"Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells","volume":"35","author":"Kokhaei","year":"2007","journal-title":"Exp Hematol"},{"key":"R23-5-20210219","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1679","article-title":"Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1","volume":"38","author":"Rosenbauer","year":"2006","journal-title":"Nat Genet"},{"key":"R24-5-20210219","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Res"},{"key":"R25-5-20210219","first-page":"24","article-title":"ATM mutations in B-cell chronic lymphocytic leukemia","volume":"59","author":"Bulrich","year":"1999","journal-title":"Cancer Res"},{"key":"R26-5-20210219","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V85.9.2315.bloodjournal8592315","article-title":"Telomerase activity in normal leukocytes and in hematologic malignancies","volume":"85","author":"Counter","year":"1995","journal-title":"Blood"},{"key":"R27-5-20210219","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T","article-title":"Telomerase activity in B-cell non-Hodgkin lymphoma","volume":"89","author":"Ely","year":"2000","journal-title":"Cancer"},{"key":"R28-5-20210219","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood-2005-04-1742","article-title":"Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells","volume":"106","author":"Mayr","year":"2005","journal-title":"Blood"},{"key":"R29-5-20210219","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.exphem.2005.09.016","article-title":"MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes","volume":"34","author":"Mayr","year":"2006","journal-title":"Exp Hematol"},{"key":"R30-5-20210219","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V94.3.1063.415a17_1063_1069","article-title":"Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset","volume":"94","author":"Rezvany","year":"1999","journal-title":"Blood"},{"key":"R31-5-20210219","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2002-03-0746","article-title":"Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia","volume":"101","author":"Rezvany","year":"2003","journal-title":"Blood"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e318183af26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:10:28Z","timestamp":1786036228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200810000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e318183af26","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}